Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 373.216 |
| 2025-03 | 418.614 |
| 2025-04 | 384.747 |
| 2025-05 | 332.816 |
| Source | Traffic Share |
|---|---|
| search | 63.59% |
| direct | 27.26% |
| referrals | 6.80% |
| social | 1.73% |
| paid referrals | 0.53% |
| 0.09% |
| Region | Percentage |
|---|---|
| United States | 19.32% |
| Australia | 10.32% |
| United Kingdom | 10.16% |
| China | 5.48% |
| VN | 5.32% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| plethysmography | 1,307 | 13,070 | $10.93 |
| long-term efficacy and safety of omalizumab in patients with allergic asthma: a real-life study | 8 | 80 | $0.00 |
| omalizumab discontinuation | 0 | 0 | $0.00 |
| classification of bronchiectasis by cause | 0 | 0 | $0.00 |
| european respiratory journal | 245 | 2,450 | $0.00 |